company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2290000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2290000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,159000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-28000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,76000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1135000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3218000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3218000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7320000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,201000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7421000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7421000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4181000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3281000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3281000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,162000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-20000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,81000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,66000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2992000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2992000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3192000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4096000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4096000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,164000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,48000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1214000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1722000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-948000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-948000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-279000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-279000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-279000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-466000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3524000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,82000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,62320000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-7320000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,51003000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,51003000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49776000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74298000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74298000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,182000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-89000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-460000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,24515000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-50150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-50150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-403000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-403000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-403000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-887000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-3058000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15774000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-155000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,304000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,160609000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,39182701.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,180221701.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,180222000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,129669000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1767000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7758000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7758000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,196000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1472000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-935000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7025000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7025000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-933000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-933000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-933000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7964000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10534000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10534000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,179000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,147000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2164000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1082000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9126000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9126000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1813000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2327000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-73619000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-73105000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-73105000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,159000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,80000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,239000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,239000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-81992000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13408000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13408000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,394000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,176000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2318000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3081000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7439000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7439000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1851000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5416000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5481000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1916000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1916000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,283000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-82000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,196000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,196000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9159000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16848000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16848000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,430000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,156000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2530000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1596000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12136000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12136000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-824000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12874000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-22549000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10499000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10499000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,1000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-95000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,482000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,389000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,389000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22246000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15075000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15075000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,463000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,169000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3065000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,141000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11237000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11237000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2293000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11183000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-21015000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12125000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12125000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-202000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,113000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14911000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14911000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8451000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16509000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16509000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,488000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,236000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3138000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-666000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13313000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13313000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2274000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4675000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1685000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,716000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,716000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,188000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,172000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,356000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,356000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12241000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17719000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17719000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,668000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,219000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3060000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2370000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11402000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11402000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1220000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9909000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3416000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5273000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5273000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,277000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5274000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5274000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-855000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19938000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19938000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,687000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,218000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3084000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1460000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14489000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14489000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1433000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16781000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7160000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8188000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8188000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,181000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,211000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,387000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,387000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5914000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1136000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21973000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21973000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,782000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,202000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3364000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4827000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22452000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22452000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1593000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21425000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-11487000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8345000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8345000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10079000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,64888000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,585000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,75552000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,75338000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,61231000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,488000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24457000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24457000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,866000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,256000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3190000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-26000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20171000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20171000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5980000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17595000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-16533000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4918000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4918000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,609000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24480000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,743000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23431000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23431000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,852000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,289000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3663000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1065000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17562000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17538000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2981000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6516000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8263000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4728000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4728000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22116000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,783000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21918000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21918000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1064000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,227000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5127000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2701000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12799000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12823000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1580000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,39000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18201000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-18612000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1952000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1952000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2389000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12386000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,937000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22840000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22840000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1426000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,186000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3605000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1055000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18678000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18672000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-416000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17275000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6312000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10547000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10547000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,828000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,821000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,821000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7304000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,784000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24175000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24175000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1774000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,256000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3573000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-416000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18988000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19029000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-639000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20535000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-26145000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6249000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6249000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,7000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,64764000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2157000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,66943000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,66913000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41635000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,552000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23801000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23801000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1716000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,141000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3676000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1553000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16715000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16680000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-266000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14429000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-18184000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4021000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4021000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20698000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1115000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27220000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27220000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1782000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,121000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2980000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1936000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20401000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20401000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-296000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59335000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19123000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,50641000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10133000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10133000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,372000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9896000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,574000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24528000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24528000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1787000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,645000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2136000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4596000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24556000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24556000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-131000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18163000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18032000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18032000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4625000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,70000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4703000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4687000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1837000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,857000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26936000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26936000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1955000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,757000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1996000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,737000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21491000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21491000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-420000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17516000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17096000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17096000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4423000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4435000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4423000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,865000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32032000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32032000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1737000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,817000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9531000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1159000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18788000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18788000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9550000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9547000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9547000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,16000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,22944000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42295000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,65255000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,65177000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,55936000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,889000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28981000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28981000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1696000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,771000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17984000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4204000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12734000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12734000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,32000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4182000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4182000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-199000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8751000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,590000.0
